Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
29.32
+1.79 (6.50%)
Jul 9, 2026, 11:17 AM EDT - Market open
Damora Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $40 | Buy | Maintains | $40 | +36.43% | Jun 30, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $45 | Buy | Maintains | $45 | +53.48% | Jun 22, 2026 |
| Wedbush | Wedbush | Buy Maintains $35 | Buy | Maintains | $35 | +19.37% | Jun 16, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 | Buy | Maintains | $40 | +36.43% | Jun 15, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $45 | Buy | Initiates | $45 | +53.48% | Jun 11, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $55 → $51 | Buy | Maintains | $55 → $51 | +73.94% | May 15, 2026 |
| Evercore ISI | Evercore ISI | Buy Initiates $46 | Buy | Initiates | $46 | +56.89% | Mar 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.